NCT00333567View on ClinicalTrials.gov

Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

August 31, 2006

Conditions
Pain
Interventions
DRUG

Lumiracoxib

Trial Locations (1)

Unknown

Novartis, Nuremberg

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00333567 - Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee Surgery | Biotech Hunter | Biotech Hunter